BLFS Q1 2023 Earnings — BioLife Solutions, Inc. Revenue & Financial Results | Market Cap Arena

BLFSBioLife Solutions, Inc.

$921M

Q1 2023 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$38M+4.1% YoY

Gross Profit

$14M37.2% margin

Operating Income

-$13M-34.2% margin

Net Income

-$14M-36.4% margin

EPS (Diluted)

$-0.32

QoQ Revenue Growth

-14.8%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$6M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$446M

Total Liabilities

$88M

Stockholders' Equity

-$261M

Cash & Equivalents

$19M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$38M	$36M	+4.1%
Gross Profit	$14M	$12M	+19.2%
Operating Income	-$13M	-$11M	-17.6%
Net Income	-$14M	-$7M	-94.1%

Revenue Segments

Rental Revenue

$4M95%

Service Revenue

$200,0005%